Insider Transactions in Q2 2025 at Checkpoint Therapeutics, Inc. (CKPT)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 30
2025
|
Fortress Biotech, Inc. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,122,249
-100.0%
|
$24,488,996
$4.1 P/Share
|
|
May 30
2025
|
Barry M Salzman Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
147,007
-100.0%
|
-
|
|
May 30
2025
|
Michael S Weiss Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
187,007
-100.0%
|
-
|
|
May 30
2025
|
Christian Bechon Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
141,718
-100.0%
|
-
|
|
May 30
2025
|
William Garrett Gray Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,446,322
-100.0%
|
-
|
|
May 30
2025
|
Neil Herskowitz Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
147,007
-100.0%
|
-
|
|
May 30
2025
|
James F Oliviero Iii CEO, President and Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,759,929
-100.0%
|
-
|
|
May 30
2025
|
Lindsay A Md Rosenwald Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
207,007
-100.0%
|
-
|
|
May 30
2025
|
Sharma Amit Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
94,246
-100.0%
|
-
|
|
May 29
2025
|
Fortress Biotech, Inc. |
SELL
Open market or private sale
|
Direct |
100,000
-1.61%
|
$100,000
$1.29 P/Share
|
|
May 29
2025
|
Michael S Weiss Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+21.1%
|
$50,000
$1.29 P/Share
|
|
May 29
2025
|
Lindsay A Md Rosenwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+19.45%
|
$50,000
$1.29 P/Share
|
|
May 28
2025
|
Barry M Salzman Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,195
+7.66%
|
-
|
|
May 28
2025
|
Michael S Weiss Director |
BUY
Grant, award, or other acquisition
|
Indirect |
12,195
+8.17%
|
-
|
|
May 28
2025
|
Christian Bechon Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,195
+7.92%
|
-
|
|
May 28
2025
|
Neil Herskowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,195
+7.66%
|
-
|
|
May 28
2025
|
Lindsay A Md Rosenwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,195
+7.21%
|
-
|
|
May 28
2025
|
Sharma Amit Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,195
+11.46%
|
-
|
|
Apr 02
2025
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
15,090
-0.4%
|
$60,360
$4.04 P/Share
|
|
Apr 01
2025
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,322
-0.84%
|
$49,288
$4.05 P/Share
|